FirstSight.Labs
AI-powered fetal MRI platform predicting birth outcomes accurately from a single 1-minute scan.
FirstSight.Labs offers an in-depth fetal MRI that complements routine prenatal care, with no ionizing radiation or contrast agent. Expectant parents receive a detailed report, shared with their OB-GYN, and keep their scans, labs and notes in one secure app.
Founders
Amine Bouachba
CEO
Amine is a French fetal medicine physician, whose work on COVID helped drive worldwide vaccination of pregnant women. At the top European maternity hospital, he laid the foundations of a new field of medicine: fetal MRI volumetry. Amine is here to disrupt the US birth injury market.